Effect of Somatic Comorbidity on Alleviation of Depressive Symptoms

Viinamäki, Heimo; Tanskanen, Antti; Hintikka, Jukka; Haatainen, Juha; Antikainen, Risto; Honkalampi, Kirsi; Haatainen, Kaisa; Koivumaa‐Honkanen, Heli; Saarinen, Pirjo; Lehtonen, Johannes

doi:10.1080/j.1440-1614.2000.00806.x

Cited by 6 publications

(3 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The follow-up time was long which can be considered as a strength. We reported earlier [29] that in this sample somatic comorbidity has only minor effect on alleviation of depressive symptoms in a 6-month follow-up and therefore this variable was not analyzed. Our sample was clinically complex because the mean duration of depressive symptoms prior to treatment was long.…”

Section: Discussionmentioning

confidence: 99%

Hopelessness and Low Social and Occupational Functioning are Associated with Non-Recovery from Depression—Results of a 6-Year Follow-Up Study

Viinamäki

Koivumaa‐Honkanen

Honkalampi

et al. 2008

Clinical Medicine Insights: Psychiatry

Self Cite

View full text Add to dashboard Cite

The aim of this study was to explore variables associated with poor recovery from depression. Method: A sample of depressive patients (n = 121) referred to treatment was followed prospectively for 6 years. Clinical evaluations were done at baseline and at 6 month, 1, 2 and 6 years study visits. A diagnosis of major depression based on SCID interview at 6 year and high BDI score along follow-up indicated poor recovery. A diagnosis of full remission at 6 year and low BDI score during follow-up indicated good recovery. Results: Chronic depression was found in 15% of patients. A repeated measures analysis of variance of HDRS-, SCL-90, hopelessness (HS) and Social and Occupational Functioning Assessment Scale (SOFAS) scores showed that those with poor recovery had recovered poorly also according these scales during the whole follow-up. Treatment factors did not associate with recovery. Logistic regression analyses revealed an independent association between poor recovery at 6 year and both high HS-and low SOFAS scores at 12 months, 24 months and 6 year assessments. Conclusions: Assessment of hopelessness and social and occupational functioning help to early identify high-risk patients who would be in need for more individually tailored treatments.

show abstract

Section: Discussionmentioning

confidence: 99%

Hopelessness and Low Social and Occupational Functioning are Associated with Non-Recovery from Depression—Results of a 6-Year Follow-Up Study

Viinamäki

Koivumaa‐Honkanen

Honkalampi

et al. 2008

Clinical Medicine Insights: Psychiatry

Self Cite

View full text Add to dashboard Cite

show abstract

“…Their depression decreased during the hospital treatment if physical symptoms were only slight, but increased if they had severe physical symptoms or diseases. However, among unspecified psychiatric outpatients the alleviation of depression was not significantly associated with somatic comorbidity [21]. Thus, longitudinal studies focusing on patients with somatic and psychiatric comorbidities or psychosomatic problems are needed.…”

Section: Introductionmentioning

confidence: 98%

The need for long-term surveillance of recovery of psychiatric patients with somatic complaints

Kokkonen¹,

Salke²,

Saharinen³

et al. 2012

OJPsych

Self Cite

View full text Add to dashboard Cite

Objective: Treatment of psychiatric patients with psychosomatic or somatic symptoms needs special attention. Methods: We examined correlates, change and recovery from depression among psychiatric patients (n = 150) during the assessment of their work ability. Patients were referred to an open psychiatric ward during 8/2004-9/2005. Psychiatric diseases were diagnosed with the ICD-10 by the psychiatrist, but also the Structured Clinical Interview for DSM-IV (SCID I and II) was conducted. The patients replied to questionnaires after admission and before discharge including questions on life changes, somatic health, psychosocial and health-related factors as well as psychometric scales for depression (BDI), life satisfaction (LS) and general psychopathology (SCL). RESULTS. At baseline, 75% of the patients reported clinically significant depression (BDI > 15) and a quarter of them experienced their depression as severe (BDI ≥ 30). Whereas, according to ICD-10 guidelines, 91% of the patients suffered from depressive disorder and 66% of them from major depression. The average duration of inpatient evaluation was 24 (SD 9, 4) days. Baseline poor general health, life dissatisfaction, psychosomatic symptoms, bodily pains as well as poor financial situation and adverse life events predicted prevailing depression at discharge. Clinical symptoms improved significantly, especially among younger patients, recovery could not be reached by the time of discharge. Conclusions: Psychiatric patients with somatic complaints tended to under-rate their depression. To enhance their recovery, long-term and individually planned out-patient treatment and surveillance are needed

show abstract

“…Being in charge of a general psychiatry unit receiving hospitalized patients with somatic comorbidity, we feel that Dr Viinamäki’s paper in the October 2000 issue of this Journal [1] raises interesting methodological questions.…”

mentioning

confidence: 99%

Depression and somatic comorbidity

Eytan

Alberque

2001

Aust N Z J Psychiatry

View full text Add to dashboard Cite

Effect of Somatic Comorbidity on Alleviation of Depressive Symptoms

Abstract: Moderate somatic comorbidity has only a minor effect on recovery from depression.

Cited by 6 publications

References 23 publications

Hopelessness and Low Social and Occupational Functioning are Associated with Non-Recovery from Depression—Results of a 6-Year Follow-Up Study

Hopelessness and Low Social and Occupational Functioning are Associated with Non-Recovery from Depression—Results of a 6-Year Follow-Up Study

The need for long-term surveillance of recovery of psychiatric patients with somatic complaints

Depression and somatic comorbidity

Contact Info

Product

Resources

About